Peripheral Clinical Brochure
6Pages

Contact your AngioScore® sales representative to find out more about our peer-reviewed publications. AngioScore, Inc. 5055 Brandin Court, Fremont, CA 94538 www.angioscore.com Tel: 510.933.7900 Fax: 510.933.7901 Toll Free: 877.264.4692 info@angioscore.com CAUTION: Federal Law (USA) restricts this device to sale by or on the order of a physician. ML-1121-0001 Rev A 01/14 US Patent No. 7022104 granted and other patents pending. © 2013 AngioScore, Inc. All Rights Reserved.

Scoring Balloon Catheter

AngioSculpt® Peer-Reviewed Publications ABSTRACTS 1. Gershony G, Virmani R, Lotan C, Konstantino E, Leon MB. A Novel Angioplasty Catheter For The Treatment Of Complex CAD: AngioSculpt®. American Journal of Cardiology September 2003; Vol. 92, Issue 6, Supplement 1: 166L. 2. Abizaid A, Feres F, Gershony G, Konstantino E, Staico R, Mattos L, Vaz V, Ferreira E, Silva CE, Sousa E. Results of the First in Man Study of the AngioSculpt Scoring Balloon Catheter. Catheterization and Cardiovascular Interventions May 2004; Vol. 62, Issue 1:117. 3. Abizaid, A, Grube E, Gershony G, Feres F, Mueller R,...

Let’s clear a few things up.

Multiple studies have shown that AngioSculpt is a tool that delivers excellent outcomes for treating peripheral artery disease. ® Studies Published in Leading Journals. Catheterization and Cardiovascular Interventions Cardiovascular Revascularization Medicine Circulation Endovascular Forum Vascular Heart and Vessel “Plaque modification is a very important step to ensure that our destination therapies, i.e., stents, are optimally deployed so that our patients have the best long term results. AngioScore is the leader in balloon-based plaque modification, with well designed trials backing up...

AngioSculpt® works. 86.3% 1-Year Limb Salvage Rate in CLI Patients. <10% Dissection Rate. Bosiers M, Deloose K et al. Use of the AngioSculpt scoring balloon for infrapopliteal lesions in patients with critical limb ischemia: 1-year outcome. Vascular. 2009;17:29-35. Stand-Alone Treatment. AngioSculpt was successfully used as a stand-alone treatment in 58%-89.3% of cases in four separate studies. Kiesz RS, Scheinert D, Peeters PJ, Bosiers M, O’Sullivan G, Sultan S, Turco MA, Gray WA, Laird JR, Malik A, Mewissen MW, Dave R, Das TS, Piemonte TC, Khanna P, Gershony G. Results From the...